{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:08:44Z","timestamp":1776100124557,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,13]]},"DOI":"10.7759\/cureus.106965","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:09:46Z","timestamp":1776096586000},"source":"Crossref","is-referenced-by-count":0,"title":["A Uterine Leiomyoma With a Novel BRAF::ABCB1 t(7; 7)(q34; q21.12) Fusion: A Case Report"],"prefix":"10.7759","author":[{"given":"Cao","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahyna","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudarshana","family":"Roychoudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology, and diagnosis of uterine myomas","volume":"87","author":"Parker WH","year":"2007","unstructured":"Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007, 87:725-36. 10.1016\/j.fertnstert.2007.01.093","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun SE","year":"2013","unstructured":"Bulun SE. Uterine fibroids. N Engl J Med. 2013, 369:1344-55. 10.1056\/NEJMra1209993","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"M\u00e4kinen N","year":"2011","unstructured":"M\u00e4kinen N, Mehine M, Tolvanen J, et al.. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011, 334:252-5. 10.1126\/science.1208930","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine M","year":"2013","unstructured":"Mehine M, Kaasinen E, M\u00e4kinen N, et al.. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013, 369:43-53. 10.1056\/NEJMoa1302736","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies H","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, et al.. Mutations of the BRAF gene in human cancer. Nature. 2002, 417:949-54. 10.1038\/nature00766","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23237","article-title":"Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer","volume":"115","author":"Ciampi R","year":"2005","unstructured":"Ciampi R, Knauf JA, Kerler R, et al.. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest. 2005, 115:94-101. 10.1172\/JCI23237","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.127","article-title":"Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance","volume":"14","author":"Schram AM","year":"2017","unstructured":"Schram AM, Chang MT, Jonsson P, Drilon A. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance. Nat Rev Clin Oncol. 2017, 14:735-48. 10.1038\/nrclinonc.2017.127","journal-title":"Nat Rev Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman MM","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002, 2:48-58. 10.1038\/nrc706","journal-title":"Nat Rev Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman PB","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, et al.. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011, 364:2507-16. 10.1056\/NEJMoa1103782","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-021-00618-y","article-title":"The future of uterine fibroid management: a more preventive and personalized paradigm","volume":"28","author":"El Sabeh M","year":"2021","unstructured":"El Sabeh M, Borahay MA. The future of uterine fibroid management: a more preventive and personalized paradigm. Reprod Sci. 2021, 28:3285-8. 10.1007\/s43032-021-00618-y","journal-title":"Reprod Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.09.024","article-title":"MED12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists","volume":"228","author":"Nagai K","year":"2023","unstructured":"Nagai K, Asano R, Sekiguchi F, Asai-Sato M, Miyagi Y, Miyagi E. MED12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists. Am J Obstet Gynecol. 2023, 228:207.e1-9. 10.1016\/j.ajog.2022.09.024","journal-title":"Am J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/diseases11040156","article-title":"Novel approaches to possible targeted therapies and prophylaxis of uterine fibroids","volume":"11","author":"Kuznetsova MV","year":"2023","unstructured":"Kuznetsova MV, Tonoyan NM, Trubnikova EV, et al.. Novel approaches to possible targeted therapies and prophylaxis of uterine fibroids. Diseases. 2023, 11:158. 10.3390\/diseases11040156","journal-title":"Diseases"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.102129","article-title":"Fumarate hydratase-deficient uterine leiomyomas in appalachian women: a case series highlighting cancer disparities in underserved white populations","volume":"18","author":"Sigdel S","year":"2026","unstructured":"Sigdel S, Pamujula S, Mahmud W, Bou Zgheib N, Diks J. Fumarate hydratase-deficient uterine leiomyomas in appalachian women: a case series highlighting cancer disparities in underserved white populations. Cureus. 2026, 18:e102129. 10.7759\/cureus.102129","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477871-a-uterine-leiomyoma-with-a-novel-brafabcb1-t7-7q34-q2112-fusion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:09:47Z","timestamp":1776096587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477871-a-uterine-leiomyoma-with-a-novel-brafabcb1-t7-7q34-q2112-fusion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.106965","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}